0001104659-24-071284.txt : 20240613
0001104659-24-071284.hdr.sgml : 20240613
20240613162120
ACCESSION NUMBER: 0001104659-24-071284
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240613
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oliviero James F III
CENTRAL INDEX KEY: 0001434718
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41264
FILM NUMBER: 241041512
MAIL ADDRESS:
STREET 1: C/O KERYX BIOPHARMACEUTICALS, INC.
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvectis Pharma, Inc.
CENTRAL INDEX KEY: 0001875558
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 862405608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
BUSINESS PHONE: 360-837-7232
MAIL ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
4
1
tm2416958-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-13
0
0001875558
Nuvectis Pharma, Inc.
NVCT
0001434718
Oliviero James F III
C/O NUVECTIS PHARMA, INC.,
1 BRIDGE PLAZA, SUITE 275
FORT LEE
NJ
07024
1
0
0
0
0
Common Stock
2024-06-13
4
A
0
30000
0
A
57828
D
The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Oliviero's continued service on the board on such dates.
/s/ James F. Oliviero III
2024-06-13